510(k) Report

510(k) · Cleared

Cleared

BreView

K233714510(k) TraditionalCleared Jan 25, 202466-day reviewClass II21 CFR 892.2050

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

GE Medical Systems SCS · LLZ System, Image Processing, Radiological

Cleared on Jan 25, 2024 as substantially equivalent to K113456 (Ge Healthcare (Ge Medical Systems Scs), 2012) after a 66-day review. Its family tree reaches back 5 generations to 1987.

Decided
Jan 25, 2024
Review
66 days
Class
Class II
Product code
LLZ
Recalls
None
Predicates
1

Its longest line of descent runs back 5 generations to K871859 (1987). 11 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 5 generations backK871859 CT9800 Quick 3D #B7919DAGeneral Electric Co. · 1987
  2. 4 generations backK972399 Advantage Windows Volume Rendering OptionGe Medical Systems, Inc. · 1997 · Recalled
  3. 3 generations backK041521 Volume Viewer PlusGeneral Electric Medical Systems · 2004 · Recalled
  4. 2 generations backK110573 Ready ViewGe Healthcare (Ge Medical Systems Scs) · 2011 · Recalled
  5. 1 generation backK113456 Ready ViewGe Healthcare (Ge Medical Systems Scs) · 2012
  6. This deviceK233714 BreViewGE Medical Systems SCS · 2024
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K871859CT9800 Quick 3D #B7919DAGeneral Electric Co.1987—
−4K972399Advantage Windows Volume Rendering OptionGe Medical Systems, Inc.19971
−3K041521Volume Viewer PlusGeneral Electric Medical Systems20042
−2K110573Ready ViewGe Healthcare (Ge Medical Systems Scs)20111
−1K113456Ready ViewGe Healthcare (Ge Medical Systems Scs)2012—
0 (this device)K233714BreViewGE Medical Systems SCS2024—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199120
199310
199510
199610
200110
FIG. 1 — Lineage of K233714, 1987–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LLZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LLZ device

  1. #1 K230955 syngo Application Softwarescore 21.5 · 11 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K113456Ready View
Summary page 4
…Class II Primary Predicate Device Device name: READY View Manufacturer: GE Medical Systems SCS 510(k) number: K113456 Primary Regulation Number: 21 CFR 892.2050 Medical image management and processing system Product Code:…
Ge Healthcare (Ge Medical Systems Scs)2012—
†K093234Integrated RegistrationGE Medical Systems SCS2009—
†K081985AW ServerGe Medical Systems, LLC20085
†K041521Volume Viewer PlusGeneral Electric Medical Systems20042
†K213725CardIQ SuiteGE Medical Systems SCS2022—

Also cleared against K113456: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 37 years and passes through 5 companies; a new generation was cleared every 6.9 years on median.
  • 5 of the 11 ancestors have a recall of any class.
  • 1 other device also cites its predicate K113456.

How does its category compare?

All LLZ devices

LLZ System, Image Processing, Radiological: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.

FDA decisions per year · LLZ

58in 2025

2007: 762008: 942009: 702010: 512011: 1062012: 822013: 952014: 782015: 642016: 822017: 782018: 1042019: 742020: 812021: 832022: 652023: 872024: 622025: 582026 (partial year): 45
2007high 106 (2011) · low 51 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LLZ

173in 2025

2007: 36 days median2008: 52 days median2009: 62 days median2010: 98 days median2011: 79 days median2012: 87 days median2013: 84 days median2014: 89 days median2015: 90 days median2016: 90 days median2017: 107 days median2018: 105 days median2019: 107 days median2020: 115 days median2021: 116 days median2022: 137 days median2023: 157 days median2024: 131 days median2025: 173 days median2026 (partial year): 110 days median
2007high 173 (2025) · low 36 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LLZ

11in 2025

2007: 202008: 322009: 212010: 172011: 302012: 122013: 642014: 62015: 162016: 122017: 52018: 72019: 22020: 62021: 32022: 42023: 82024: 62025: 112026 (partial year): 14
2007high 64 (2013) · low 2 (2019)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LLZ

116in 2025

2007: 1522008: 1542009: 1452010: 1452011: 4542012: 2662013: 1,1302014: 15,6312015: 2112016: 2902017: 1042018: 722019: 882020: 822021: 702022: 282023: 262024: 422025: 116
2007high 15,631 (2014) · low 26 (2023)2025

MAUDE reports naming product code LLZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007763620152
2008945232154
2009706221145
2010519817145
20111067930454
2012828712266
20139584641,130
20147889615,631
2015649016211
2016829012290
2017781075104
2018104105772
201974107288
202081115682
202183116370
202265137428
202387157826
202462131642
20255817311116
20264511014—

What is it indicated for?

BreView is a tool to aid clinicians with the review of multi-parametric breast magnetic resonance (MR) images. The combination of acquired images, reconstructed images, annotations, and measurements performed by the clinician are intended to provide the referring physician with clinically relevant information that may aid in diagnosis and treatment planning.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K233714: BreView.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K233714

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026